It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Originally posted by ButterCookie
We are not mistaken:
VeriChip Corporation (“VeriChip”) CHIP and its development partner RECEPTORS LLC ("RECEPTORS"), a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced webcast details for today's event for the medical, patient and investor communities in New York to unveil details of their virus triage detection system for the H1N1 virus and Phase II development of an in vivo glucose-sensing RFID microchip
and
RECEPTORS LLC develops SMART MATERIALS products for laboratory, clinical, industrial hygiene and healthcare use that selectively capture and measure chemical, biochemical and cellular targets from complex biological, environmental or industrial samples. The Company's patented AFFINITY by DESIGN™ platform has broad applicability, ranging from the isolation of disease pathway proteins for drug discovery and production of therapeutic antibodies, to the capture of bacteria and viruses for disinfection and diagnostic purposes. RECEPTORS LLC is a private company based in suburban Minneapolis, Minnesota. For further information please visit www.receptorsllc.com...
and
VeriChip Corporation, headquartered in Delray Beach, Florida, has developed the VeriMed™ Health Link System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip and corresponding personal health record, cleared for medical use in October 2004 by the United States Food and Drug Administration.
On September 8, 2009, VeriChip Corporation announced it agreed to acquire Steel Vault Corporation SVUL to form PositiveID Corporation. PositiveID will provide identification technologies and tools to protect consumers and businesses. The companies expect the merger to close in the fourth quarter of 2009.
so please tell me where we have misread......
virus triage detection system for the H1N1 virus AND Phase II development of an in vivo glucose-sensing RFID microchip
Is the CDC Purposely Misinforming the Public to Sell More Flu and H1N1 Vaccines?
Conflicts of interest are rampant in the vaccination infrastructure. The same people who are regulating and promoting vaccines are also evaluating vaccine safety.
For instance, Dr. Paul Offit of the Children's Hospital of Philadelphia earned at least $29 million as part of a $182-million sale by the hospital of its worldwide royalty interest in the Merck Rotateq vaccine. He also formerly sat on the CDC's Advisory Committee on Immunization Practices (ACIP) to help create the market for rotavirus vaccine
This type of conflict of interest has been going on for some time.
In August 1999, the Committee on Government Reform initiated an investigation into Federal vaccine policy. During the investigation the Committee extensively reviewed financial disclosure forms and related documents and interviewed key officials from the Food and Drug Administration (FDA) and the CDC.
the company said it had been granted an exclusive license to two patents, which will help it to develop implantable virus detection systems in humans.
The patents, held by VeriChip partner Receptors LLC, relate to biosensors that can detect the H1N1 and other viruses, and biological threats such as methicillin-resistant Staphylococcus aureus, VeriChip said in a statement.
The technology will combine with VeriChip's implantable radio frequency identification devices to develop virus triage detection systems.
The triage system will provide multiple levels of identification -- the first will identify the agent as virus or non-virus, the second level will classify the virus and alert the user to the presence of pandemic threat viruses and the third level will identify the precise pathogen, VeriChip said in a white paper published May 7, 2009
Originally posted by ButterCookie
reply to post by wanderingwaldo
Once again....
(and this was released by Reuters, by the way)
the company said it had been granted an exclusive license to two patents, which will help it to develop implantable virus detection systems in humans.
The patents, held by VeriChip partner Receptors LLC, relate to biosensors that can detect the H1N1 and other viruses, and biological threats such as methicillin-resistant Staphylococcus aureus, VeriChip said in a statement.
The technology will combine with VeriChip's implantable radio frequency identification devices to develop virus triage detection systems.
The triage system will provide multiple levels of identification -- the first will identify the agent as virus or non-virus, the second level will classify the virus and alert the user to the presence of pandemic threat viruses and the third level will identify the precise pathogen, VeriChip said in a white paper published May 7, 2009
Now I don't have anything to gain from this ( I don't work for Verichip), just stating facts from MSN, Reuters, and Verichip's own website. Please please prove us wrong...show me (from the above article released by Reuters) where Verichip has not pattened a virus-detecting RFID chip?
I understand that the prior articel mentioned two pattents....the two pattents together is this triage system.
By any chance, did anyone see Stephen King's "The Stand" way back in 1994? Not only was the swine flu EXPLICITELY part of the plot, but this is how it played out...
1) Swine flu
2) Martial Law(along the way, Kathy Bates, who played an Alex Jones character, got killed while speaking out on the airwaves)
3) A nuclear bomb went off
For the last few years, the MSM has been fearmongering and conditioning us with a big nuke attack to hit here from Al Qaeda - through all this time, they ended up taking everyone's eyeballs off of what the NWO was doing(the elite bankers committing more thefts like this massive bank bailout bill, and then stirring up this swine flu).